Home >> Industry News >> FDA authorizes COVID-19 breathalyzer test

FDA authorizes COVID-19 breathalyzer test

image_pdfCreate PDF

In a study of 2,409 people, including those with and without symptoms, the test was shown to have 91.2 percent sensitivity and 99.3 percent specificity. Positive test results should be confirmed with a molecular test.

CAP TODAY
X